maintains stability of the human telomerase RNA (TERC) by interacting with H/ACA consensus sequence in TERC. Pathogenic mutations in DKC1 result in a dysfunctional protein, leading to reduced levels of TERC, decreased telomerase activity, and premature telomere shortening in males [3] . Dyskerin has a role also in controlling ribosome biogenesis [3] . X-chromosome inactivation (XCI) silences transcription from one of the two X chromosomes in female cells to balance expression dosage between males and females. The inactivation process is sometimes incomplete in human tissues, thus up to one-third of X-chromosomal genes may be expressed from both the active and silenced X chromosomes [3] . There are few reports on females with DKC1 mutation [4] [5] [6] . Here, we report results of detailed molecular and clinical investigation of three symptomatic sisters aiming at enlightening X-linked TBD in females.
We recently identified two brothers with a novel DKC1 mutation c.1218_1219insCAG, p.(Asp406_Ser407insGln) resulting in short telomeres and manifestation of DC [6] . Three female siblings (mother and two aunts of the brothers) were studied at the Department of Hematology in Helsinki University Hospital Comprehensive Cancer Center in 2016-2017 amid hematologic consultation of the brothers. Clinical examination and sampling for extended routine analyses, as well as research laboratory analyses, were performed for all the females. Informed consents were obtained from participating individuals. This study was conducted in accordance with the principles of Helsinki Declaration and was approved by the Ethics Committee of Helsinki University Hospital (#206/13/03/03/2016). Detailed descriptions of the study subjects and analyses are presented in Fig. 1 All the females were confirmed to be heterozygous DKC1 mutation carriers by Sanger sequencing. In order to study X-inactivation in various tissues, we compared the DKC1 expression levels and distribution of wild type (WT) and mutant alleles in blood, buccal mucosa, tongue, and Epstein-Barr virus (EBV)-transformed lymphocytes using Sanger sequencing and droplet digital PCR (ddPCR). ddPCR is superior to traditional quantitative PCR as it is more sensitive and allows absolute quantitative measurement of RNA expression [7] (Fig. 2) . With ddPCR, the mutant allele burden in blood was 0% in the mother, 45% in aunt 1, and 5% in aunt 2. Also, buccal mucosa and tongue samples showed varying amounts of mutant DKC1 allele expression in all the females (Fig. 2) . Although we observed both mutant and WT alleles to be present, e.g., in blood samples, it is possible, or even likely, that signals come from different cells expressing either WT or mutant DKC1, and not both. The EBV-transformed lymphocytes showed extremely high overall DKC1 expression, >98% being WT DKC1 (Supplementary Figure 1) . Dyskerin expression has been reported to be similar in EBV-transformed lymphoblastoid cells in mutation carrying females vs. controls [8] .
Here, we show that the extremely high DKC1 expression in transformed cells does not reflect the situation in naïve cells. This is not surprising as such, since dyskerin expression increases with malignant transformation [9] . Consequently, EBV-transformed lymphoblastoid cells should not be used in evaluation of telomere functionality.
The telomere lengths (TL) were measured in whole blood by a quantitative PCR-based method [10] . Two out of the three females (mother and the aunt 1) had shortened telomeres compared to age-matched controls (Supplementary Figure 2 ). The telomeres in the two brothers were previously shown to be very short (<5th percentile) and are depicted in the same figure for comparison. According to the literature, there is not a strict relationship between TL and severity of symptoms at an individual level [11] . Families have been reported where individuals display variable symptoms and differences in telomere lengths even though they carry the same mutation [12, 13] . Also, gene/ mutation-specific effect on TL is unclear. The brothers with extremely short TL had clear clinical mucocutaneous and immunological manifestations of DC. However, in the females, the correlation of TL with clinical presentation was less obvious and inquired more detailed investigation. The expression of DKC1 measured by ddPCR in blood correlated better with, e.g., anemia.
In DKC1-linked TBD, skewed X-inactivation has been thought to function especially well in hematopoietic tissues [6] and protect females from hematologic symptoms. In our study, both mutant and WT DKC1 are expressed in blood in two out of three females. They both have suffered from marginal macrocytic anemia for some years. Bone marrow biopsy examination in aunt 2 showed mild hypoplasia and explained for the findings in the blood picture. It is highly likely that also aunt 1 has corresponding findings in her bone marrow, although sampling has been postponed due to more urgent ophthalmologic procedures. Interestingly, and in accordance with previous findings in patients with DC, all the carrier females had elevated levels of hemoglobin F potentially suggesting for stress hematopoiesis and bone marrow failure syndrome. It has been speculated whether clonal hematopoiesis can precede myeloid malignancy in patients with DC. Thus, potential development of clonal hematopoiesis in the two aunts with anemia was investigated by a myeloid nextgeneration sequencing panel. Neither of the patients had any somatic mutations in genes involved in myeloid neoplasms, corresponding well to recent findings [14] . A long-term surveillance of genomic evolution in DC patients is still indicated aiming at early detection of MDS.
Regarding other clinical findings in our study patients, at least two of the three females had abnormal early graying of hair and nail atypia (Supplementary Table 1 ). Also, subtle dermatologic features indicative of DC were present in both aunts (Supplementary Figure 3) . However, they lacked the typical reticular pigmentation of the head and neck.
In summary, we demonstrate here that in rare diseases such as TBDs, careful clinical and molecular examination of one family can significantly increase our knowledge on disease features. Despite X-linked inheritance, two out of three females in this study fulfill the diagnostic criteria for DC-or DC-like syndrome [1] . In conjunction with widening the clinical spectrum of DKC1-linked TBD in women, we are also able to reveal the molecular roots of patients' symptoms. Whether the unique distribution pattern of mutant and WT DKC1 in distinct tissues arises by co- incidence or is a controlled biological phenomenon, remains to be investigated. DC is a multi-organ disease with high incidence of developing malignancies [2] . Since the health problems in female DKC1 mutation carriers may also be significant, the identification, registration, and careful follow-up of these individuals is called for.
